Helping Young People With Testicular Cancer Using Virtual and Extended Reality
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age15-39
SponsorGustave Roussy, Cancer Campus, Grand Paris
About this trial
TRANSCEND-XR is a European research project designed to better support adolescents and young adults who have been cured of testicular cancer. Even after treatment has ended, many young people continue to face physical, psychological, or social difficulties that are often poorly understood and insufficiently addressed.
The project aims to develop an innovative digital tool using extended reality (XR) to help these young people better understand the potential long-term effects of the disease and its treatments, recognize signs that require medical attention, and become more active participants in their own health follow-up.
TRANSCEND-XR first includes a pilot phase to test feasibility and improve the tool, followed by a larger clinical study comparing its use with usual medical follow-up. Researchers will assess, in particular, its impact on patients' knowledge, quality of life, and ability to seek help.
The ultimate goal is to sustainably improve information, autonomy, and well-being among young survivors of testicular cancer through a digital approach tailored to their needs and daily practices.
Eligibility criteria
Qualifiers
Any person assigned male at birth who is diagnosed with stage I-III TC (germ cell tumour of the testicles).
Aged between 15 and 39 years at the time of study inclusion.
Completed curative treatment comprising of at least one standard treatment modality (surgery, chemotherapy and/or radiotherapy) for treatment of their cancer. A maximum of 9 months from the end of curative treatment will be allowed.
Localised disease: orchiectomy with or without chemotherapy and/or radiotherapy.
Disqualifiers
Non-testicular germ cell tumours (e.g., mediastinal primary or retroperitoneal primary tumours).
Non-germ cell TC.
Previous chemotherapy, radiotherapy, or surgery for TC other than that allowed in IC 4.
History of contralateral TC.
Trial design
Treatments tested in this trial
- Digital tool using extended reality
Treatment groups
245 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov